Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

David Price; Andrew M Wilson; Alison Chisholm; Anna Rigazio; Anne Burden; Michael Thomas; Christine King

doi:10.2147/JAA.S97973

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

J Asthma Allergy. 2016 Jan 7:9:1-12. doi: 10.2147/JAA.S97973. eCollection 2016.

Authors

David Price¹, Andrew M Wilson², Alison Chisholm³, Anna Rigazio⁴, Anne Burden⁴, Michael Thomas⁵, Christine King⁴

Affiliations

¹ Centre for Academic Primary Care, The Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; Research in Real-Life, Cambridge, UK.
² Norwich Medical School, University of East Anglia, Norwich, UK.
³ Respiratory Effectiveness Group, Cambridge, UK.
⁴ Research in Real-Life, Cambridge, UK.
⁵ Primary Medical Care, University of Southampton, Southampton, UK.

Abstract

Purpose: Acute, severe asthma exacerbations can be difficult to predict and thus prevent. Patients who have frequent exacerbations are of particular concern. Practical exacerbation predictors are needed for these patients in the primary-care setting.

Patients and methods: Medical records of 130,547 asthma patients aged 12-80 years from the UK Optimum Patient Care Research Database and Clinical Practice Research Datalink, 1990-2013, were examined for 1 year before (baseline) and 1 year after (outcome) their most recent blood eosinophil count. Baseline variables predictive (P<0.05) of exacerbation in the outcome year were compared between patients who had two or more exacerbations and those who had no exacerbation or only one exacerbation, using uni- and multivariable logistic regression models. Exacerbation was defined as asthma-related hospital attendance/admission (emergency or inpatient) or acute oral corticosteroid (OCS) course.

Results: Blood eosinophil count >400/µL (versus ≤400/µL) increased the likelihood of two or more exacerbations >1.4-fold (odds ratio [OR]: 1.48 (95% confidence interval [CI]: 1.39, 1.58); P<0.001). Variables that significantly increased the odds by up to 1.4-fold included increasing age (per year), female gender (versus male), being overweight or obese (versus normal body mass index), being a smoker (versus nonsmoker), having anxiety/depression, diabetes, eczema, gastroesophageal reflux disease, or rhinitis, and prescription for acetaminophen or nonsteroidal anti-inflammatory drugs. Compared with treatment at British Thoracic Society step 2 (daily controller ± reliever), treatment at step 0 (none) or 1 (as-needed reliever) increased the odds by 1.2- and 1.6-fold, respectively, and treatment at step 3, 4, or 5 increased the odds by 1.3-, 1.9-, or 3.1-fold, respectively (all P<0.05). Acute OCS use was the single best predictor of two or more exacerbations. Even one course increased the odds by more than threefold (OR: 3.75 [95% CI: 3.50, 4.01]; P<0.001), and three or more courses increased the odds by >25-fold (OR: 25.7 [95% CI: 23.9, 27.6]; P<0.001).

Conclusion: Blood eosinophil count and several other variables routinely available in patient records may be used to predict frequent asthma exacerbations.

Keywords: exacerbator; hospitalization; multiple; risk.